Objectives: To assess the impact of the introduction of the SIGN Clinical guidelines in 1999 and subsequent revision in 2005 on tonsillectomy, hospital admission with tonsillitis and peritonsillar abscess rates in four countries. Methods: Retrospective analysis using English, Welsh, Australian and New Zealand National healthcare hospital admission databases between 2000 and 2013. Primary outcomes measures included tonsillectomy rates and hospital admission rates for tonsillitis and peritonsillar abscess. Secondary outcome measures included bed-day usage in England and Wales. Linear forecasting was used to identify the potential impact of any trends. Results: Following guideline introduction for tonsillectomy, a significant decline in tonsillectomy rates in England (P < 0.01) and Wales (P < 0.05) was seen. Hospital admissions for acute tonsil infections increased in England (P < 0.01) and Wales (P < 0.01). In Australia and New Zealand, tonsillectomy and admission for tonsillitis rates both increased (P < 0.01). During this time, the increased rate of admission for tonsillitis in England and Wales was significantly greater than Australasia (P < 0.01). Conclusions: Following the introduction of these Clinical guidelines, there was a decrease in the rate of tonsillectomy in England and Wales and a presumed associated increase in admissions with tonsillitis. This did not occur in Australasia where tonsillectomy rates rose over time. If these trends continue, it is likely that they will have a significant deleterious impact on healthcare spending in the future.
Tonsillectomy is one of the most frequently performed surgical procedures in both children and adults in the UK. Evidence on the effectiveness of tonsillectomy is conflicting with some literature suggesting tonsillectomy causes a significant improvement on health-related quality of life as well and conferring additional secondary economic health benefits from reduced general practitioner (GP) attendances and a reduction in occupational absenteeism. [1] [2] [3] [4] In contrast to this, however, some literature exists to suggest tonsillectomy is unnecessary 5 and unjustified in certain cases. The latter opinion was highlighted by the 2009 McKinsey National Health Service report 6 which, in addition to this, 7 suggested tonsillectomy to consume significant NHS resources (in terms of cost and bed utilisation) in a time of financial difficulty. Where applications have been made, a significant number of funding requests have been refused leading to restricted tonsillectomy rates. With the introduction of much stricter guidance on the criteria required for surgical intervention for tonsillitis, the UK government has been exerting increasing pressure to reduce the number of tonsillectomies performed in the past 10 years 8 even though clinicians have stated ongoing concerns over the consequences of acute infection of the tonsils. 9, 10 In 2005, Croydon PCT deemed 35 procedures of limited clinical effectiveness (PoLCE), one of which was tonsillectomy. 11 This was widely adapted by the Audit Commission throughout the UK despite evidence that tonsillectomy does have significant benefits in the treatment of sore throat. 12, 13 Due to these changes, PCTs are now required to apply for funding when performing PoLCE procedures. This study aimed to investigate the presence of trend change over time in tonsillectomy rates, the incidence of hospital admission for the consequences of acute tonsil infection (tonsillitis and quinsy) and the effect on bed-day utilisation in the period following the introduction of stringent requirements for surgical management of recurrent tonsillitis and quinsy within the UK. The study assessed this data from England and Wales against data from Australia and New Zealand. 16 ; and (iv) New Zealands Health Statistics database (NZHS) supplied by New Zealands Ministry of Health.
Materials and methods

A
Tonsillitis episodes were identified in PEDW, AIHW, HES and NZHS using the ICD primary diagnosis code J03. Tonsillectomy was identified using operations codes F341-F349, excluding code F346 (excision of lingual tonsil). Peritonsillar abscess was identified using ICD primary diagnosis code J36.
The data from the UK National Statistics website, 17 the Australian Bureau of Statistics website 18 and the Statistics New Zealand 19 website were used to calculate annual incidence per 1000 population using mid-year population estimates of the countries under review. For those years in which population estimates were not available, the mean increase in population over the previous 10 years was used to estimate the true population. Extracted data were examined for differences in demographic and practice between the three national cohorts as well as for changes in provision of tonsillectomy surgery over the period of the study. The effect of rates of tonsillectomy and tonsillitis on the number of bed days used in the UK was also investigated. Within each country, trends were evaluated using a linear regression model and differences between countries using one-way ANOVA. Data were analysed using SPSS version 20 with a P value of <0.05 was taken as statistically significant.
Ethical considerations
Ethical review was not sought as this data are anonymised and freely available to the public.
Results
A total of 1 041 954 tonsillectomies were performed in the four countries over the period 2000-2013 as shown in Fig. 1a (no data were available from Australia between 2012 and 2013). Using linear regression analysis from 2000 to the SIGN 117 update of 2005, no statistically significant trend change was seen in tonsillectomy rates in England, Wales and Australia (P = 0.392, P = 0.547, P = 0.74). New Zealand, however, showed a significant decrease in tonsillectomy rates between the same period (P = 0.013, t = 0.363). A comparison of the rates of tonsillectomy between countries using multiple ANOVA identified greater operations per head of population in Australia than in England (P < 0.01) and Wales (P < 0.01) before SIGN update of 2005. There was no significant difference in operation rates between New Zealand and the other three countries. Following the SIGN guidelines update in the UK, there was a significant decrease in rates of tonsillectomy in England (P < 0.01, t = À6.07) and Wales (P < 0.05, t = À5.296). This is despite an increase in the numbers of tonsillectomies performed in England between 2000 and 2013 from 46 331 to 48 422. However, these increases have not kept pace with population growth. Conversely in Australia and New Zealand, tonsillectomy rates showed a significant increase (Australia -P < 0.05, t = 4.977, New Zealand P < 0.01, t = 7.77). A comparison of the rates of tonsillectomy after 2005 showed that both Australia and New Zealand now had significantly greater rates of tonsillectomy when compared to England (P < 0.01) and Wales (P < 0.01).
Between 2000 and 2013, there were 999 354 admissions to hospital with acute infection of the tonsil. A total of 846 111 admissions were due to tonsillitis as shown in Fig. 1b and 153 243 due to peritonsillar abscess as shown in Fig. 1c .
There was a significant increase in the rates of tonsillitis admission pre-2005 SIGN update for both England (P < 0.01, t = 6.855) and New Zealand (P < 0.05, t = 4.02). There was no significant change for Wales (P = 0.352) and Australia (P = 0.536). The rates of tonsillitis were significantly greater in Wales than all three other countries during this time period (P < 0.01).
Post-2005 SIGN117 all four countries showed an increase in tonsillitis rates (P < 0.05). However, a comparison of the rates between countries using multiple ANOVA showed that the rate of tonsillitis was now greater in England and Wales when compared to Australia and New Zealand (P < 0.01).
There was no significant change in peritonsillar abscess admissions in all four countries both between 2000 and 2005 as well as 2005 and 2013. A comparison of the relative rates of peritonsillar abscess between countries showed that Wales rates were significantly greater pre-2005 (P < 0.05) as well as post-2005 (P < 0.05) when compared to the other three countries.
The average bed-day utilisation for tonsillectomy in England and Wales was 0.45. With a total of 615 185 bed days used for tonsillectomy over the 13-year period as shown in Fig. 2a . During this time, bed-day numbers in England dropped substantially from 52 229 in 2000 to 28 474 in 2012. Linear regression analysis showed this reduction was significant (P < 0.01, t = À11.4). Wales showed a similar trend with a significant reduction in bed days (P < 0.01, t = À1.53). Conversely, bed-day utilisation for tonsillitis in England increased from 29 880 in 2000 to 48 494 in 2012 (Fig. 2a) . Linear regression analysis between 2000 and 2013 showed that this was significant for England (P < 0.01, t = 5.129) and Wales (P < 0.01, t = 4.43).
Linear forecasting estimating bed-day use for tonsillitis in 2020 predicted that there would be a 175% increase in England and 80% increase in Wales when compared to 2000 levels. Forecasting of bed-day usage for tonsillectomy in 2020 predicted that there will be a 96% reduction in England and 60% reduction in Wales.
The ratio in 2000 of tonsillectomy/tonsillitis bed usage was 1.73. However in 2012, the ratio had reversed to 0.58, indicating that greater number of bed days are now used by tonsillitis when compared by tonsillectomy.
Using linear forecasting, estimates of the rates of tonsillectomy and tonsillitis were made in 2020 for each country. It was found that there will be a predicted 21% decrease in tonsillectomy rate in England and 45% decrease in Wales. Predicted rates for 2020 in Australia increased by 89% and in New Zealand by 35%.
Linear forecasts of the rates of tonsillitis in 2020 showed large increases in England and Wales (393%, 238%). Increases were also predicted in Australia and New Zealand (52%, 76%). The unseen costs of tonsillitis and quinsy on hospital bed consumption 575
Discussion
In 1999, the Scottish Intercollegiate Guidelines Network (SIGN) first published guidelines for the management of sore throats/recurrent acute tonsillitis that were designed to be an aid to both GPs as well as otolaryngologists in providing effective health care. These guidelines gave specific criteria in the management of acute infective tonsillitis with guidance for referral and nationally recognised indications for performing tonsillectomies. 20, 21 Following a consultation document in 2005, these SIGN guidelines were updated in April 2010 13 bringing them in line with AAOHNS guidelines. Current specific recommendations for consideration of tonsillectomy due to tonsillitis are seen in Table 1 . This study assessed trends in tonsillectomy rates and hospital admissions for tonsillitis and peritonsillar abscess following the introduction of SIGN 117 in the UK. Trend analysis was also performed in Australia and New Zealand, as national controls.
Since the 2005 update of SIGN guidelines, tonsillectomy rates reduced significantly in England and Wales with an inverse increasing rate of hospital admission for the consequences of acute tonsil infection. These changes were not seen in the Australian or New Zealand national cohort where a gradual increase in admission trend for tonsillitis has been recognised.
Within the confines of this study, it is not possible to directly link the reduction in tonsillectomies in England and Wales to the introduction of SIGN 117 guidelines; however, it appears that over this time period, a significant reduction in tonsillectomy rates did occur with a reciprocal increase in hospital admission for complications related to untreated tonsillitis. In Australia where SIGN 117 was not introduced, tonsillectomy rate increased significantly and there was little change in hospital admissions for tonsillitis. The results suggest there is, to a degree, an inverse relationship between hospital admission for tonsillitis and tonsillectomy rates, with this theory being supported by the findings in the Australian and New Zealand national cohorts. Similar findings have previously been identified by Lau et al. 22 who deduced that the introduction of PoLCE from 2005 may have had a significant negative impact on tonsillectomy rates but rising numbers of sore throat related admissions may have negated any savings from tonsillectomy. It must be recognised that correlation does not imply causation and that other factors may have had an unknown influence on our findings such as differences in coding accuracy over time within the same country as well as differences between countries.
Over the same time period, there was a significant change in bed-day utilisation for both tonsillectomy and admission for acute tonsillitis and quinsy. Over the 13-year period, both England and Wales showed a significant reduction in bedday utilisation for tonsillectomy, whereas the utilisation for tonsillitis increased in both countries. This may be a causeand-effect principle with reduced rates of tonsillectomies increasing the threshold at which the procedure was being offered to patients, leading to more hospital admissions with tonsillitis and quinsy.
A confounding factor that must be considered is that over the same period of time there has been increased usage of same day discharge of tonsillectomy patients which may account for the decrease. However, this does not explain the large increase in bed utilisation in those with tonsillitis or quinsy. This trend may be a sign of an increasing overall societal burden which would greatly underestimate school and working days lost and warrants further future study.
Linear forecasting of bed-day usage predicting levels in 2020 showed that there will be significant reductions in bedday use for tonsillectomy (96% reduction in England and 61% in Wales when compared to 2000 levels) and large increases in bed-day use for tonsillitis (175% increase in use when compared to 2000 levels in England and 80% increase in Wales). Although significant savings can be made by reducing tonsillectomy rates, this study suggests that this is being offset by increasing admissions with tonsillitis.
Conclusion
National guidelines have many benefits including clarity of referral as well as providing a baseline for when to perform an intervention. This study has highlighted that the introduction of the SIGN sore throat guidelines may have the previously unforeseen side-effect of increased presentations with tonsillitis. This is further demonstrated by the fact that although bed-day utilisation has decreased for tonsillectomy in England and Wales, the utilisation for tonsillitis has increased. A potentially unrecognised financial impact of this could manifest in the form of increased GP attendances in the healthcare services that adopt such guidelines. There may also be a wider social impact in the form of patients taking time off for sick leave. Further research is needed to investigate whether there is a definite causal link between the introduction of the SIGN guidelines and the reduction in Table 1 . Tonsillectomy considerations due to tonsillitis Recurrent severe sore throat in adults Episodes of sore throat are disabling and prevent normal functioning Seven or more well-documented, clinically significant, adequately treated sore throats in the preceding year Five or more such episodes in each of the preceding 2 years Three or more such episodes in each of the preceding 3 years tonsillectomy rates and increased admission for tonsillitis/ quinsy.
Keypoints
• Decreasing rates of tonsillectomy and increasing rates of hospital admissions for tonsillitis were identified in England and Wales between 2000-2013.
• SIGN Clinical guidelines on tonsillectomy were introduced in 1999 and subsequently reviewed in 2005 in England and Wales, and not in Australia and New Zealand.
• In Australia and New Zealand tonsillectomy and tonsillitis rates were found to increase. However the increase in tonsillitis admissions were smaller than those seen in England and Wales.
• Although no association is proven, it maybe that savings made in the NHS by reducing tonsillectomy rates is being offset by increasing burden of disease from tonsillitis.
